Literature DB >> 12151798

Measurements of water diffusion and T1 values in peritumoural oedematous brain.

Mark E Bastin1, Saurabh Sinha, Ian R Whittle, Joanna M Wardlaw.   

Abstract

Using quantitative MR imaging, values for the mean water diffusivity (<D>), the diffusion anisotropy and the longitudinal relaxation time (T1) were measured for tumour, oedematous and normal brain in a group of treatment-naive patients with high-grade glioma and low-grade meningioma. The mean values of <D> and T1 for enhancing tumour and oedematous brain were significantly higher in high-grade glioma than meningioma, while the diffusion anisotropy was reduced. Values of <D> and T1 were also positively correlated in oedematous brain in both pathologies. There was, however, no clear evidence of similar correlations in apparently normal contralateral white matter. Such results illustrate the potential of MR imaging to improve not only the characterization of brain oedema, but also the monitoring of treatment response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12151798     DOI: 10.1097/00001756-200207190-00024

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  19 in total

Review 1.  Diffusion tensor imaging of the brain: review of clinical applications.

Authors:  P C Sundgren; Q Dong; D Gómez-Hassan; S K Mukherji; P Maly; R Welsh
Journal:  Neuroradiology       Date:  2004-04-21       Impact factor: 2.804

2.  Diffusion tensor imaging at the crossroads: fiber tracking meets tissue characterization in brain tumors.

Authors:  Aaron S Field
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

Review 3.  Functional Neuroimaging: Fundamental Principles and Clinical Applications.

Authors:  Nishanth Khanna; Wilson Altmeyer; Jiachen Zhuo; Andrew Steven
Journal:  Neuroradiol J       Date:  2015-05-11

4.  Brain Morphometry and Longitudinal Relaxation Time of Spontaneously Hypertensive Rats (SHRs) in Early and Intermediate Stages of Hypertension Investigated by 3D VFA-SPGR MRI.

Authors:  Sunil Koundal; Xiaodan Liu; Simon Sanggaard; Kristian Mortensen; Joanna Wardlaw; Maiken Nedergaard; Helene Benveniste; Hedok Lee
Journal:  Neuroscience       Date:  2019-01-26       Impact factor: 3.590

5.  Rapid multicontrast brain imaging on a 0.35T MR-linac.

Authors:  Siamak P Nejad-Davarani; Niloufar Zakariaei; Yongsheng Chen; E Mark Haacke; Newton J Hurst; M Salim Siddiqui; Lonni R Schultz; James M Snyder; Tobias Walbert; Carri K Glide-Hurst
Journal:  Med Phys       Date:  2020-07-06       Impact factor: 4.071

6.  Diffusion imaging for therapy response assessment of brain tumor.

Authors:  Thomas L Chenevert; Brian D Ross
Journal:  Neuroimaging Clin N Am       Date:  2009-11       Impact factor: 2.264

7.  Evaluation of human brain tumor heterogeneity using multiple T1-based MRI signal weighting approaches.

Authors:  Manus J Donahue; Jaishri O Blakeley; Jinyuan Zhou; Martin G Pomper; John Laterra; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2008-02       Impact factor: 4.668

8.  Differentiation of edema and glioma infiltration: proposal of a DTI-based probability map.

Authors:  Friso W A Hoefnagels; Philip De Witt Hamer; Ernesto Sanz-Arigita; Sander Idema; Joost P A Kuijer; Petra J W Pouwels; Frederik Barkhof; W Peter Vandertop
Journal:  J Neurooncol       Date:  2014-07-31       Impact factor: 4.130

9.  Improved conspicuity and delineation of high-grade primary and metastatic brain tumors using "restriction spectrum imaging": quantitative comparison with high B-value DWI and ADC.

Authors:  N S White; C R McDonald; N Farid; J M Kuperman; S Kesari; A M Dale
Journal:  AJNR Am J Neuroradiol       Date:  2012-11-08       Impact factor: 3.825

10.  Imaging signatures of meningioma and low-grade glioma: a diffusion tensor, magnetization transfer and quantitative longitudinal relaxation time MRI study.

Authors:  Rory J Piper; Shadia Mikhael; Joanna M Wardlaw; David H Laidlaw; Ian R Whittle; Mark E Bastin
Journal:  Magn Reson Imaging       Date:  2015-12-17       Impact factor: 2.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.